title: Edema Extension Distance: Outcome Measure for Phase II Clinical Trials Targeting Edema After Intracerebral Hemorrhage.
authors.affiliation: From the Centre for Vascular and Stroke Research, Manchester Academic Health Sciences Centre, Salford Royal NHS Foundation Trust (A.R.P.-J., A.V.) and Centre for Biostatistics (A.V.), University of Manchester, Manchester, United Kingdom; Greater Manchester Comprehensive Stroke Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom (A.R.P.-J.); Neurological and Mental Health Division, The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia (X.W., S.S., C.S.A.); and Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD (W.A.M., D.F.H.). adrian.parry-jones@manchester.ac.uk.
authors.forename: Adrian R
authors.initials: AR
authors.lastname: Parry-Jones
authors.affiliation: From the Centre for Vascular and Stroke Research, Manchester Academic Health Sciences Centre, Salford Royal NHS Foundation Trust (A.R.P.-J., A.V.) and Centre for Biostatistics (A.V.), University of Manchester, Manchester, United Kingdom; Greater Manchester Comprehensive Stroke Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom (A.R.P.-J.); Neurological and Mental Health Division, The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia (X.W., S.S., C.S.A.); and Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD (W.A.M., D.F.H.).
authors.forename: Xia
authors.initials: X
authors.lastname: Wang
authors.affiliation: From the Centre for Vascular and Stroke Research, Manchester Academic Health Sciences Centre, Salford Royal NHS Foundation Trust (A.R.P.-J., A.V.) and Centre for Biostatistics (A.V.), University of Manchester, Manchester, United Kingdom; Greater Manchester Comprehensive Stroke Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom (A.R.P.-J.); Neurological and Mental Health Division, The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia (X.W., S.S., C.S.A.); and Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD (W.A.M., D.F.H.).
authors.forename: Shoichiro
authors.initials: S
authors.lastname: Sato
authors.affiliation: From the Centre for Vascular and Stroke Research, Manchester Academic Health Sciences Centre, Salford Royal NHS Foundation Trust (A.R.P.-J., A.V.) and Centre for Biostatistics (A.V.), University of Manchester, Manchester, United Kingdom; Greater Manchester Comprehensive Stroke Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom (A.R.P.-J.); Neurological and Mental Health Division, The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia (X.W., S.S., C.S.A.); and Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD (W.A.M., D.F.H.).
authors.forename: W Andrew
authors.initials: WA
authors.lastname: Mould
authors.affiliation: From the Centre for Vascular and Stroke Research, Manchester Academic Health Sciences Centre, Salford Royal NHS Foundation Trust (A.R.P.-J., A.V.) and Centre for Biostatistics (A.V.), University of Manchester, Manchester, United Kingdom; Greater Manchester Comprehensive Stroke Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom (A.R.P.-J.); Neurological and Mental Health Division, The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia (X.W., S.S., C.S.A.); and Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD (W.A.M., D.F.H.).
authors.forename: Andy
authors.initials: A
authors.lastname: Vail
authors.affiliation: From the Centre for Vascular and Stroke Research, Manchester Academic Health Sciences Centre, Salford Royal NHS Foundation Trust (A.R.P.-J., A.V.) and Centre for Biostatistics (A.V.), University of Manchester, Manchester, United Kingdom; Greater Manchester Comprehensive Stroke Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom (A.R.P.-J.); Neurological and Mental Health Division, The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia (X.W., S.S., C.S.A.); and Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD (W.A.M., D.F.H.).
authors.forename: Craig S
authors.initials: CS
authors.lastname: Anderson
authors.affiliation: From the Centre for Vascular and Stroke Research, Manchester Academic Health Sciences Centre, Salford Royal NHS Foundation Trust (A.R.P.-J., A.V.) and Centre for Biostatistics (A.V.), University of Manchester, Manchester, United Kingdom; Greater Manchester Comprehensive Stroke Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom (A.R.P.-J.); Neurological and Mental Health Division, The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia (X.W., S.S., C.S.A.); and Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD (W.A.M., D.F.H.).
authors.forename: Daniel F
authors.initials: DF
authors.lastname: Hanley
mesh_terms: D001929:Brain Edema / Q000209:etiology / Q000517:prevention & control*; D002543:Cerebral Hemorrhage / Q000150:complications / Q000628:therapy*; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D006801:Humans; D008297:Male
keywords: brain edema; cerebral hemorrhage; clinical trials